AAZ |
acetazolamide |
Absorp. |
absorption |
ADMET |
absorption, distribution, metabolism, excretion, and toxicity |
AMP |
ampicillin |
BHI |
brain hearth infusion |
BRZ |
brinzolamide |
CA |
carbonic anhydrase |
cat. |
catalyst |
CLSI |
Clinical and Laboratory Standards Institute |
CNS |
central neural system |
Comp. |
compound |
DCP |
dichlorphenamide |
DMEM |
Dulbecco’s modified Eagle medium |
DMF |
N,N-dimethylformamide |
DMSO |
dimethyl sulfoxide |
DOX |
doxorubicin |
DZA |
dorzolamide |
E. faecalis
|
Enterococcus faecalis
|
E. faecium
|
Enterococcus faecium
|
EMA |
European Medicines Agency |
EZA |
ethoxzolamide |
FDA |
Food and Drug Administration |
FTIR |
Fourier transform infrared spectroscopy |
hCA |
human carbonic anhydrase |
HERG |
human ether-a-go-go-related gene |
IFD |
induced-fit docking |
IND |
indisulam |
MD |
molecular dynamic |
MIC |
minimum inhibitory concentration |
MM/GBSA |
molecular mechanics generalized Born surface area |
MRSA |
methicillin-resistant S. aureus
|
MTT |
methylthiazolyldiphenyl-tetrazolium bromide |
MZA |
methazolamide |
NMR |
nuclear magnetic resonance |
NT |
not tested |
PBC |
periodic boundary conditions |
PBS |
phosphate buffered saline |
PDB |
protein data bank |
PME |
particle mesh Ewald |
RMSD |
root mean square deviation |
S. aureus
|
Staphylococcus aureus
|
sp. |
species |
supp. |
supported |
TLC |
thin-layer chromatography |
TMS |
tetramethylsilane |
TOX |
toxicity |
VAN |
vancomycin |
VMD |
visual molecular dynamics |
VRE |
vancomycin-resistant enterococci |
WHO |
World Health Organization |